Safety and Immunogenicity of the LEISH-F2 + MPL-SE Vaccine With SSG for Patients With PKDL
Condition(s):Post Kala Azar Dermal LeishmaniasisLast Updated:June 27, 2011Completed
Hide Studies Not Open or Pending
Condition(s):Post Kala Azar Dermal LeishmaniasisLast Updated:June 27, 2011Completed
Condition(s):PKDLLast Updated:July 10, 2012Completed
Condition(s):HealthyLast Updated:February 19, 2018Completed
Condition(s):HealthyLast Updated:February 17, 2011Completed
Condition(s):HealthyLast Updated:November 18, 2009Completed
Condition(s):Zika; Dengue; Malaria; Chikungunya; LeishmaniasisLast Updated:December 8, 2021Completed
Condition(s):Visceral Leishmaniasis; Human African Trypanosomiasis; Enteric Fever; Melioidosis; Brucellosis; Leptospirosis; Relapsing Fever; Rickettsial Diseases; HIV; Tuberculosis; Malaria; Amoebic Liver AbscessLast Updated:October 27, 2016Completed
Condition(s):QTc-intervalLast Updated:May 4, 2020Completed
Condition(s):Diabetic FootLast Updated:November 6, 2012Completed
Condition(s):HIV InfectionLast Updated:August 8, 2011Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.